Dendritic cells: Specialized antigen presenting cells

Research output: Contribution to journalArticlepeer-review


Renewing interest in cancer immunotherapy reflects the excellent results that have been obtained in animal models and the promising results in early clinical trails with dendritic cell (DC) based approaches. The central role that DCs play in the initiation of an immune response raises the possibility of using them to trigger specific anti-tumor immunity. In addition, deeper knowledge of DC biology will allow better understanding of the mechanism(s) underlying allergic and autoimmune diseases as well as tolerance phenomena. These crucial issues were critically reviewed during a workshop organized by the Italian Society for Experimental Hematology in Florence, Italy, on March 18th, 1999. The chairmen have prepared this report for the readers of Haematologica. (C) 2000, Ferrata Storti Foundation.

Original languageEnglish
Pages (from-to)202-207
Number of pages6
Issue number2
Publication statusPublished - Feb 2000


  • Antigen presenting cells
  • Dendritic cells
  • Gene therapy
  • Immunotherapy

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Dendritic cells: Specialized antigen presenting cells'. Together they form a unique fingerprint.

Cite this